A Clinical Study of MIL62 in Primary Membranous Nephropathy
Condition: Primary Membranous Nephropathy Interventions: Drug: MIL62; Drug: Cyclosporine Sponsor: Beijing Mabworks Biotech Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials